Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 8;15(1):501-507.
doi: 10.1515/med-2020-0173. eCollection 2020.

Bladder-embedded ectopic intrauterine device with calculus

Bing-Jian Xiong  1 , Guang-Jing Tao  1 , Duo Jiang  1
Affiliations

Bladder-embedded ectopic intrauterine device with calculus

Bing-Jian Xiong et al. Open Med (Wars). .

Erratum in

Abstract

The present study aimed to analyze the data of embedded intrauterine device (IUD) in the bladder wall with the additional presence of calculus. This case series study included 11 female patients with partially or completely embedded IUD in the bladder wall. Their median age was 34 (range, 32-39) years. The median duration of IUD placement was 36 (range, 24-60) months. The median duration of symptoms was 9 (range, 3-12) months. Six patients underwent laparoscopy: the operation duration was 129 (range, 114-162) min, blood loss was 15 (range, 10-25) mL, the hospital stay was 4 (range, 4-4.5) days, the visual analog scale (VAS) for pain at 6 h after surgery was 3 (range, 2-6), and the time to removal of the urethral catheter was 7 (range, 7-8) days. Five patients underwent open surgery: the operation duration was 126 (range, 96-192) min, blood loss was 30 (range, 20-50) mL, the hospital stay was 7 (range, 7-15) days, the VAS was 6 (range, 4-9) at 6 h after surgery, and the time to removal of the urethral catheter was 9 (range, 8-17) days. The IUD and bladder stones were successfully removed in all 11 (100%) patients.

Keywords: cystectomy; intrauterine device; intrauterine device migration; laparoscopy; surgery; urinary bladder; urinary bladder calculi.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The ectopic IUD was examined by pelvic radiography and computed tomography (CT) and was found to be embedded in the bladder wall and wrapped with a calculus. (a) A 34-year-old patient, gravida 2, para 2 (case #1). The patient got pregnant after IUD insertion. After the induced abortion, a new IUD was inserted. The patient suffered from abdominal pain and hematuria for half a year. Two IUDs can be seen, one is in the uterus (yellow arrow), and the other is embedded in the left posterior wall of the bladder (red arrow). (b) A 33-year-old patient, gravida 2, para 1 (case #2). The patient suffered from abdominal pain and hematuria for 1 year. The ectopic IUD was completely embedded in the posterior wall of the bladder (red arrow). (c) A 34-year-old patient, gravida 2, para 2 (case #5). The patient suffered from intermittent hematuria and urodynia for 9 months. The IUD was completely shifted in the bladder (red arrow).
Figure 2
Figure 2
The IUD and associated calculus. (a) The IUD was an MYCu, one end of which was wrapped with the calculus. (b) The IUD was embedded in the bladder wall. (c) Normal appearance of the MYCu IUD. (d) Normal appearance of the Multiload Cu IUD.
See this image and copyright information in PMC

References

    1. Espey E, Ogburn T. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol. 2011;117(3):705–19. 10.1097/AOG.0b013e31820ce2f0. - DOI - PubMed
    2. Espey E, Ogburn T. Long-acting reversible contraceptives: intrauterine devices and the contraceptive implant. Obstet Gynecol. 2011;117(3):705–19. doi: 10.1097/AOG.0b013e31820ce2f0. - DOI - PubMed
    1. Stoddard A, McNicholas C, Peipert JF. Efficacy and safety of long-acting reversible contraception. Drugs. 2011;71(8):969–80. 10.2165/11591290-000000000-00000. - DOI - PMC - PubMed
    2. Stoddard A, McNicholas C, Peipert JF. Efficacy and safety of long-acting reversible contraception. Drugs. 2011;71(8):969–80. doi: 10.2165/11591290-000000000-00000. - DOI - PMC - PubMed
    1. Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB, et al. U.S. medical eligibility criteria for contraceptive use. MMWR Recomm Rep. 2016;65(3):1–103. 10.15585/mmwr.rr6503a1. - DOI - PubMed
    2. Curtis KM, Tepper NK, Jatlaoui TC, Berry-Bibee E, Horton LG, Zapata LB. et al. U.S. medical eligibility criteria for contraceptive use. MMWR Recomm Rep. 2016;65(3):1–103. doi: 10.15585/mmwr.rr6503a1. - DOI - PubMed
    1. Buhling KJ, Zite NB, Lotke P, Black K, Group IW. Worldwide use of intrauterine contraception: a review. Contraception. 2014;89(3):162–73. 10.1016/j.contraception.2013.11.011. - DOI - PubMed
    2. Buhling KJ, Zite NB, Lotke P, Black K, Group IW. Worldwide use of intrauterine contraception: a review. Contraception. 2014;89(3):162–73. doi: 10.1016/j.contraception.2013.11.011. - DOI - PubMed
    1. Aoun J, Dines VA, Stovall DW, Mete M, Nelson CB, Gomez-Lobo V. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol. 2014;123(3):585–92. 10.1097/AOG.0000000000000144. - DOI - PubMed
    2. Aoun J, Dines VA, Stovall DW, Mete M, Nelson CB, Gomez-Lobo V. Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol. 2014;123(3):585–92. doi: 10.1097/AOG.0000000000000144. - DOI - PubMed

LinkOut - more resources